{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T13:07:28Z","timestamp":1781096848448,"version":"3.54.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,10]]},"DOI":"10.7759\/cureus.110593","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T12:35:38Z","timestamp":1781094938000},"source":"Crossref","is-referenced-by-count":0,"title":["In Vitro Susceptibility of Methicillin-Resistant Staphylococcus aureus to Ceftaroline: A Prospective Observational Study From a Tertiary Care Hospital in North India"],"prefix":"10.7759","author":[{"given":"Gaurav","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balram","family":"Omar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanya","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minakshi","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandhiya P","family":"Palanisamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anshima","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)30413-3","article-title":"Transmission of Staphylococcus aureus between health-care workers, the environment, and patients in an intensive care unit: a longitudinal cohort study based on whole-genome sequencing","volume":"17","author":"Price JR","year":"2017","unstructured":"Price JR, Cole K, Bexley A, et al.. Transmission of Staphylococcus aureus between health-care workers, the environment, and patients in an intensive care unit: a longitudinal cohort study based on whole-genome sequencing. Lancet Infect Dis. 2017, 17:207-14. 10.1016\/S1473-3099(16)30413-3","journal-title":"Lancet Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5005\/jp-journals-10071-23337","article-title":"Methicillin-resistant Staphylococcus aureus in intensive care unit setting of India: a review of clinical burden, patterns of prevalence, preventive measures, and future strategies","volume":"24","author":"Mehta Y","year":"2020","unstructured":"Mehta Y, Hegde A, Pande R, et al.. Methicillin-resistant Staphylococcus aureus in intensive care unit setting of India: a review of clinical burden, patterns of prevalence, preventive measures, and future strategies. Indian J Crit Care Med. 2020, 24:55-62. 10.5005\/jp-journals-10071-23337","journal-title":"Indian J Crit Care Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1128\/jb.158.2.513-516.1984","article-title":"Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus","volume":"158","author":"Hartman BJ","year":"1984","unstructured":"Hartman BJ, Tomasz A. Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus. J Bacteriol. 1984, 158:513-6. 10.1128\/jb.158.2.513-516.1984","journal-title":"J Bacteriol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/0255-0857.19892","article-title":"Prevalence and antimicrobial susceptibility pattern of methicillin resistant Staphylococcus aureus: a multicentre study","volume":"24","author":"Rajaduraipandi K","year":"2006","unstructured":"Rajaduraipandi K, Mani KR, Panneerselvam K, Mani M, Bhaskar M, Manikandan P. Prevalence and antimicrobial susceptibility pattern of methicillin resistant Staphylococcus aureus: a multicentre study. Indian J Med Microbiol. 2006, 24:34-8. 10.4103\/0255-0857.19892","journal-title":"Indian J Med Microbiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq252","article-title":"Ceftaroline activity against pathogens associated with complicated skin and skin structure infections: results from an international surveillance study","volume":"65","author":"Jones RN","year":"2010","unstructured":"Jones RN, Mendes RE, Sader HS. Ceftaroline activity against pathogens associated with complicated skin and skin structure infections: results from an international surveillance study. J Antimicrob Chemother. 2010, 65:iv17-31. 10.1093\/jac\/dkq252","journal-title":"J Antimicrob Chemother"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr095","article-title":"Ceftaroline fosamil: a new broad-spectrum cephalosporin","volume":"66 Suppl 3","author":"Laudano JB","year":"2011","unstructured":"Laudano JB. Ceftaroline fosamil: a new broad-spectrum cephalosporin. J Antimicrob Chemother. 2011, 66 Suppl 3:iii11-8. 10.1093\/jac\/dkr095","journal-title":"J Antimicrob Chemother"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1089\/sur.2015.209","article-title":"Antimicrobial activity of ceftaroline tested against Staphylococcus aureus from surgical skin and skin structure infections in US medical centers","volume":"17","author":"Sader HS","year":"2016","unstructured":"Sader HS, Farrell DJ, Flamm RK, Jones RN. Antimicrobial activity of ceftaroline tested against Staphylococcus aureus from surgical skin and skin structure infections in US medical centers. Surg Infect (Larchmt). 2016, 17:443-7. 10.1089\/sur.2015.209","journal-title":"Surg Infect (Larchmt)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.5001\/omj.2022.22","article-title":"Prevalence of methicillin-resistant Staphylococcus aureus in India: a systematic review and meta-analysis","volume":"37","author":"Patil SS","year":"2022","unstructured":"Patil SS, Suresh KP, Shinduja R, et al.. Prevalence of methicillin-resistant Staphylococcus aureus in India: a systematic review and meta-analysis. Oman Med J. 2022, 37:e440. 10.5001\/omj.2022.22","journal-title":"Oman Med J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10020165","article-title":"The minimum inhibitory concentration of antibiotics: methods, interpretation, clinical relevance","volume":"10","author":"Kowalska-Krochmal B","year":"2021","unstructured":"Kowalska-Krochmal B, Dudek-Wicher R. The minimum inhibitory concentration of antibiotics: methods, interpretation, clinical relevance. Pathogens. 2021, 10:165. 10.3390\/pathogens10020165","journal-title":"Pathogens"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm E","year":"2007","unstructured":"von Elm E, Altman D, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007, 370:1453-7. 10.1016\/S0140-6736(07)61602-X","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2200","article-title":"Waves of resistance: Staphylococcus aureus in the antibiotic era","volume":"7","author":"Chambers HF","year":"2009","unstructured":"Chambers HF, Deleo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol. 2009, 7:629-41. 10.1038\/nrmicro2200","journal-title":"Nat Rev Microbiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1086\/533590","article-title":"Epidemiology of methicillin-resistant Staphylococcus aureus","volume":"46 Suppl 5","author":"Boucher HW","year":"2008","unstructured":"Boucher HW, Corey GR. Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2008, 46 Suppl 5:S344-9. 10.1086\/533590","journal-title":"Clin Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu C","year":"2011","unstructured":"Liu C, Bayer A, Cosgrove SE, et al.. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011, 52:e18-55. 10.1093\/cid\/ciq146","journal-title":"Clin Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00019-10","article-title":"Affinity of ceftaroline and other \u03b2-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae","volume":"54","author":"Kosowska-Shick K","year":"2010","unstructured":"Kosowska-Shick K, McGhee PL, Appelbaum PC. Affinity of ceftaroline and other \u03b2-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae. Antimicrob Agents Chemother. 2010, 54:1670-7. 10.1128\/AAC.00019-10","journal-title":"Antimicrob Agents Chemother"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1086\/655827","article-title":"Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection","volume":"51","author":"Corey GR","year":"2010","unstructured":"Corey GR, Wilcox M, Talbot GH, et al.. Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection. Clin Infect Dis. 2010, 51:641-50. 10.1086\/655827","journal-title":"Clin Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmmb.2021.08.003","article-title":"In vitro activity of ceftaroline and other antimicrobial agents against Gram positive bacterial isolates: descriptive study from a university hospital","volume":"40","author":"Siddiqui T","year":"2022","unstructured":"Siddiqui T, Sahu C, Patel SS. In vitro activity of ceftaroline and other antimicrobial agents against Gram positive bacterial isolates: descriptive study from a university hospital. Indian J Med Microbiol. 2022, 40:101-4. 10.1016\/j.ijmmb.2021.08.003","journal-title":"Indian J Med Microbiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/475821-in-vitro-susceptibility-of-methicillin-resistant-staphylococcus-aureus-to-ceftaroline-a-prospective-observational-study-from-a-tertiary-care-hospital-in-north-india","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T12:35:39Z","timestamp":1781094939000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/475821-in-vitro-susceptibility-of-methicillin-resistant-staphylococcus-aureus-to-ceftaroline-a-prospective-observational-study-from-a-tertiary-care-hospital-in-north-india"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.110593","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,10]]}}}